Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Modified Phase I/II Trial Of Rapamycin In Patients With Glioblastoma Multiforme

NCT00047073 is registered in ClinicalTrials.gov with Jonsson Comprehensive Cancer Center as lead sponsor.

NCT NCT00047073
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00047073 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Modified Phase I/II Trial Of Rapamycin In Patients With Glioblastoma Multiforme
Lead sponsor
Jonsson Comprehensive Cancer Center
Phase
Phase 1/2
Overall status
Completed
Start date
July 31, 2002
Completion date
October 31, 2007
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors